Luvu Brands, Inc.
ATLANTA, GA / ACCESSWIRE / March 1, 2024 / Luvu Brands, Inc. (OTCQB:LUVU), a designer, manufacturer, and marketer of a portfolio of consumer lifestyle brands, today announced the appointment of Chris Knauf as Chief Financial Officer, effective February 20, 2024. He has succeeded Martin Scott, who stepped down on February 20, 2024, following the filing of the 10-Q Quarterly Report for the period.
Chris Knauf brings over two decades of corporate finance and accounting experience working with public and private companies of all sizes, scopes, and industry sectors. From 2018 to 2024, Mr. Knauf served as Senior Vice President of Accounting for Locumtenens.com, the largest medical staffing company in the United States. Prior to Locumtenens, Chris was CEO/CFO of Built NY, a lifestyle consumer products company. Before joining Built, Mr. Knauf held executive positions with the History Channel's international consumer products division and Martha Stewart Omnimedia e-commerce division.
"We are excited to welcome Chris Knauf to Luvu Brands," said Louis Friedman, Founder, and Chief Executive Officer. "Chris brings significant finance expertise, strategic planning capabilities, and deep experience at a range of consumer product companies. His skills and leadership are an excellent fit as we execute our strategic plans for growth and increased profitability."
"I am excited to join Luvu Brands at this phase of the company," said Chris Knauf. "LUVU has the opportunity to see significant growth in value through disciplined planning and careful execution. I look forward to working with the entire LUVU team to build strategy and structure that will accelerate profitable growth and shareholder value creation."
About Luvu Brands
Luvu Brands, Inc. designs, manufactures, and markets a portfolio of consumer lifestyle brands through the Company's websites, online mass merchants, and specialty retail stores worldwide. Brands include: Liberator®, a brand category of iconic products for enhancing sexual performance; Avana®, sleep comfort pillows including inclined bed therapy products, assistive in relieving medical conditions associated with acid reflux, and surgery recovery, and Jaxx®, a diverse range of casual fashion daybeds, sofas, and beanbags made from polyurethane foam and repurposed polyurethane foam trim.
Headquartered in Atlanta, Georgia, the Company occupies a 140,000 square foot vertically-integrated manufacturing facility and employs over 200 people.
The Company's brand sites include: www.liberator.com, www.jaxxbeanbags.com, www.avanacomfort.com plus other global e-commerce sites. For more information about Luvu Brands, please visit www.luvubrands.com.
Company Contact:
Luvu Brands, Inc.
Chris Knauf
Chief Financial Officer
Phone #: 770.246.6424
Email: chris.knauf@LuvuBrands.com
Forward-Looking Statements
This press release contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties. Such forward-looking statements can be identified using words such as "should", "may", "intends", "anticipates", "believes", "estimates", "projects", "forecasts", "expects", "plans", and "proposes". These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict. You are urged to carefully review and consider any cautionary statements, and other disclosures, including the statements made under LUVU's Annual Report on Form 10-K for the fiscal year ended June 30, 2023, as filed with the Securities and Exchange Commission (the SEC) and our other filings with the SEC. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are generally outside the control of LUVU and are difficult to predict. LUVU does not undertake any duty to update any forward-looking statements except as may be required by law. The information which appears on our websites and our social media platforms, including, but not limited to, Instagram and Facebook, is not part of this press release.
SOURCE: Luvu Brands, Inc.
View the original press release on accesswire.com
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESSWIRE
Subscribe to releases from ACCESSWIRE
Subscribe to all the latest releases from ACCESSWIRE by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESSWIRE
15 Companies Pitch Their Capabilities at GA-ASI’s Blue Magic Netherlands2.12.2024 13:00:00 CET | Press release
Nov. 19 Event Hosted by GA-ASI and Supported by Lockheed Martin Ventures and Brainport Attracts Cross-Section of Netherlands' High-Tech Sector SAN DIEGO, CA / ACCESSWIRE / December 2, 2024 / On November 19, 2024, General Atomics Aeronautical Systems, Inc. (GA-ASI) hosted its first Blue Magic Netherlands (BMN) event in Eindhoven, the Netherlands. Approximately 200 people attended the event that provided Dutch businesses with an opportunity to present their capabilities to GA-ASI and other companies interested in possible collaborations. GA-ASI was joined for the event by the Netherlands Ministry of Economic Affairs, the Netherlands Ministry of Defence, Lockheed Martin Ventures, Brainport Development, Brabant Development Agency (BOM), the Netherlands Industries for Defence & Security (NIDV), and SpaceNED. At this event, GA-ASI and its partners heard first-hand from Dutch companies about the important capabilities they are developing. The process started in July when GA-ASI put out an ope
BioNxt Solutions Announces Development of Sublingual Thin-Film for Semaglutide2.12.2024 03:05:00 CET | Press release
VANCOUVER, BC / ACCESSWIRE / December 2, 2024 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience company specializing in advanced drug delivery systems, announces the development of a sublingual thin-film oral dissolvable film (ODF) for Semaglutide, internally identified as BNT24005. This innovative product is intended to address limitations of existing administration methods for a therapeutic developed by Novo Nordisk, with the aim of improving patient accessibility and convenience. This product is currently under development and remains subject to regulatory review and approval. Semaglutide: A Proven Therapeutic Leader Semaglutide, developed by Novo Nordisk and marketed under brand names such as Ozempic® and Wegovy®, has revolutionized treatment for Type 2 diabetes and obesity. By mimicking glucagon-like peptide-1 (GLP-1), it enhances insulin secretion, reduces appetite, and slows gastric emptying, offering powerful tools for glycemi
GoodData Launches FlexConnect: Connect to Any Data Source & Transform Data at Run-Time2.12.2024 03:00:00 CET | Press release
SAN FRANCISCO, CA / ACCESSWIRE / December 2, 2024 / Today, GoodData introduces FlexConnect, an advanced component of the GoodData Analytics Lake that redefines data connectivity and computation. FlexConnect enables organizations to: Connect to any data source, including APIs, databases, and ML systems. Execute custom computation logic directly into the data connection using Python, Rust, and other popular languages. Integrate transformed results into GoodData's FlexQuery for further BI computation Render results through any endpoint, GoodData's UI, your UI, or through our APIs and SDKs. "FlexConnect solves a longstanding problem for analytics teams by eliminating the need to wait for vendors to build integrations. With FlexConnect, you can build high-performance connections to a wide range of sources-cloud-based, on-premises, hybrid, SQL, NoSQL, APIs, or machine learning models," said Ryan Dolley, VP of Product Strategy at GoodData. FlexConnect's differentiation lies in its use of Apac
HotelRunner Triumphs as the 'Best Large Technology Supplier' at the Travolution Awards29.11.2024 04:00:00 CET | Press release
HotelRunner, the trailblazing platform for travel and hospitality technologies, has been named the ‘Best Large Technology Supplier' at the Travolution Awards 2024 in the United Kingdom. Selected by the esteemed Travolution Awards jury, this recognition underscores HotelRunner's commitment to innovation and excellence, driving the travel industry forward with data-driven, AI-powered solutions. LONDON, UK / ACCESSWIRE / November 29, 2024 / HotelRunner, the trailblazing platform for travel and hospitality technologies, has been awarded the prestigious "Best Large Technology Supplier" title at the Travolution Awards 2024. The event, held on Nov. 28 in London, celebrated leaders in travel and technology and recognized drivers of innovation and excellence. HotelRunner was selected by a globally respected jury from among six companies competing in the same category, including software companies, tour operator platforms, and SaaS providers. This award recognizes large travel tech companies tha
DEXIS Attends ADF, Showcases Award-Winning Solutions28.11.2024 09:30:00 CET | Press release
QUAKERTOWN, PA / ACCESSWIRE / November 28, 2024 / The latest AI-powered launches from DEXIS enhance diagnostics and patient care. At ADF, DEXIS showcased its innovative product line, including the new intraoral scanners and imaging products. The conference took place November 26-30 at the Palais des Congrès de Paris in Porte Maillot, France. The company's comprehensive range of award-winning solutions covers a complete digital diagnostic workflow, from intraoral scanning and implant planning to sensors, CBCT, and imaging software. With an expanded portfolio and ecosystem, DEXIS Solutions is designed to accelerate workflows, increase productivity, and improve the patient experience. "Our technology makes it easy to organize information and execute treatments, which is at the core of what clinicians expect from us," said DEXIS President, Robert Befidi. "We are connecting and standardizing the implant workflow while also constantly evaluating our efforts to ensure we provide deeper patien
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom